益生菌保健品市場－全球產業規模、佔有率、趨勢、機會及預測：按形態、最終用途、應用、地區和競爭格局分類，2021-2031年

全球益生菌膳食補充劑市場預計將從 2025 年的 91.9 億美元成長到 2031 年的 172.1 億美元，複合年成長率高達 11.02%。

益生菌膳食補充劑是經過精心配製的產品，主要成分為活性微生物，例如細菌和酵母，旨在透過維持或恢復腸道菌叢的自然平衡來提供特定的健康益處。該市場的成長主要得益於全球對預防醫學日益成長的興趣，以及消費者對消化健康與全身免疫功能之間關鍵關聯的認知不斷加深。這些潛在促進因素代表著人們對透過飲食進行長期健康維護和疾病預防的態度發生了重大轉變，而不僅僅是曇花一現的消費趨勢。然而，由於嚴格的法律制度對健康聲明和產品穩定性進行監管，該行業面臨巨大的挑戰。因此，製造商必須投入大量資金進行科學檢驗，以確保菌株的活性並符合標籤法規。這種複雜的監管環境可能會成為新品牌進入市場的障礙，並減緩產品創新的步伐。根據國際益生菌協會預測，到2024年，美洲將佔全球益生菌補充劑零售市場的34%，凸顯了進入這個成熟市場所需的激烈競爭和高標準。

市場促進因素

消費者對腸道健康與整體健康之間複雜聯繫的認知不斷提高，正在推動市場發生顯著變革。這一點尤其體現在人們日益認知到微生物群對包括體重管理和消化器官系統功能在內的多種生理功能的影響。 GLP-1製劑的廣泛應用進一步推動了這一趨勢，益生菌被用於減輕胃腸道副作用並改善整體消化健康。根據凱利集團2025年6月的一項消費者認知調查，91%的GLP-1使用者表示，他們會向接受類似治療的人推薦特定的BC30益生菌製劑。這表明，存在一個具有洞察力的消費群體，他們不僅將益生菌視為消化輔助品，更將其視為複雜醫療方案和綜合健康策略的重要補充。此外，全球範圍內對預防性和積極主動的醫療保健的重視，也同時推動了對日常補充劑攝入的穩定需求。消費者越來越傾向於長期健康管理而非症狀治療，從而對特定類別的益生菌保持持續的興趣。根據責任營養委員會 (CRN) 於 2025 年 2 月發布的《2024 年膳食補充劑消費者調查》，75% 的美國人繼續服用膳食補充劑，其中益生菌與助眠產品一起，繼續保持頂級專業產品的地位。這種前瞻性的觀點在新興市場尤其明顯，這些市場可支配收入的成長和健康素養的提高相輔相成。國際益生菌協會 (IPA) 預測，亞太地區將在 2024 年成為全球最暢銷的地區，並將在 2028 年前保持 9.2% 的年均成長率，超過其他成熟地區，這反映了該地區的蓬勃發展。

市場挑戰

對健康聲明和產品穩定性的嚴格監管框架仍然是全球益生菌膳食補充劑市場蓬勃發展的一大障礙。與傳統膳食補充劑不同，益生菌含有活性微生物，需要進行廣泛且成本高昂的穩定性測試，以確保其從生產到消費的整個過程中保持活性。監管機構對健康聲明採用嚴格的標準，迫使製造商投入大量資金進行科學檢驗和臨床試驗，以確保符合標籤要求。這種沉重的財務負擔迫使企業將資源從市場擴張和消費者教育中轉移出來，直接減緩了新產品上市的速度，並抑制了整個產業的成長動能。因此，這些複雜的監管規定提高了市場進入門檻，對中小企業和新興品牌的影響尤其嚴重，因為它們往往缺乏滿足這些要求所需的資金。這種情況導致市場由成熟的大型企業主導，限制了能夠滿足不斷變化的消費者健康需求的多樣化創新解決方案的湧入。根據國際益生菌協會2024年的預測，未來四年全球益生菌補充劑市場預計將以7.5%的年成長率成長。然而，這種積極的成長軌跡一直受到監管障礙的阻礙，限制了產品更快多樣化和更廣泛市場滲透的潛力。

市場趨勢

隨著消費者越來越重視腸腦軸在維護心理健康和提升壓力耐受力方面的應用，益生菌的興起正在為市場帶來顯著變化。這一趨勢超越了傳統的消化器官系統健康應用，益生菌被定位為有助於調節情緒和改善睡眠品質的功能性工具。製造商正積極回應，將經臨床驗證能夠調節神經傳導物質生成的特定菌株商業化，以滿足那些將心理健康視為身體活力重要組成部分的消費者的需求。根據責任營養委員會 (CRN) 於 2025 年 2 月發布的《2024 年膳食補充劑消費者調查》，19% 的消費者表示心理健康是他們服用膳食補充劑的主要原因，22% 的消費者表示睡眠健康是他們的主要原因，這表明該品類的吸引力已遠遠超出腸道健康範疇。同時，益生菌在運動營養領域的應用正在重新定義積極生活方式領域。各大品牌正在開發「蛋白質加強型」解決方案，將益生菌融入其中，以增強營養吸收、減少運動引起的發炎並支持運動員的免疫恢復。這種整合正在推動益生菌從單一片劑形式轉向功能性粉末和飲料，並使其在活性營養市場中佔據主流地位。這項轉變的驅動力是消費者對強化蛋白質食品需求的激增，這為基於合益素的營養強化創造了沃土。根據Frizlandcampina Ingredients於2025年1月發布的《2025年營養趨勢報告》，全球71%的消費者在飲食中優先考慮蛋白質，這一以金額為準較2022年的59%顯著成長。這表明，能夠添加到高蛋白產品中的益生菌菌株蘊藏著巨大的商機。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球益生菌與保健品市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 按劑型（咀嚼軟糖、膠囊、粉末、錠劑/軟膠囊、其他）
  • 依用途（嬰兒、兒童、成人、老年人）
  • 依用途（運動與健身、能量與體重管理、一般健康、骨骼與關節健康、胃腸道健康、免疫力、心臟健康、糖尿病、抗癌、皮膚、頭髮與指甲、大腦與心理健康、其他）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美益生菌與保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲益生菌與保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區益生菌與保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲益生菌和保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美益生菌與保健品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球益生菌與保健品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Probiotics Dietary Supplements Market is projected to expand significantly, growing from USD 9.19 Billion in 2025 to USD 17.21 Billion by 2031, at an impressive CAGR of 11.02%. Probiotics dietary supplements are carefully crafted formulations containing living microorganisms, primarily bacteria and yeasts, designed to deliver specific health benefits by maintaining or restoring the gut microbiome's natural balance. This market growth is fundamentally propelled by a worldwide focus on preventive healthcare and consumers' increasing understanding of the crucial connection between digestive well-being and overall immune function. These foundational drivers represent a significant shift in how individuals approach long-term wellness and disease prevention through their diets, rather than being mere transient consumption trends. However, the sector faces substantial challenges from the stringent regulatory environment governing health claims and product stability. This necessitates considerable investment from manufacturers in scientific validation to ensure both strain viability and compliance with labeling regulations. Such regulatory complexities can impede market entry and slow the pace of product innovation for newer brands. In 2024, the Americas region notably captured 34% of the global probiotic supplements retail market, according to the International Probiotics Association, underscoring the intense competition and high standards required for market penetration in established areas.

Market Driver

Consumer awareness regarding the intricate link between gut health and systemic well-being is profoundly transforming the market, as individuals increasingly acknowledge the microbiome's influence on broader physiological systems, particularly in areas like weight management and metabolic function. This trend is further amplified by the growing use of GLP-1 medications, with probiotics being adopted to alleviate gastrointestinal side effects and enhance overall digestive comfort. A June 2025 'Consumer Perception Study' by Kerry Group revealed that 91% of GLP-1 medication users would recommend a specific BC30 probiotic formulation to others on similar treatment regimens, indicating a discerning consumer base that perceives probiotics as essential complements to complex medical treatments and comprehensive wellness strategies, beyond simple digestive aids. A global shift towards proactive and preventive healthcare is simultaneously driving consistent demand for daily supplementation. Consumers are increasingly prioritizing long-term wellness approaches over reactive treatments, leading to sustained engagement with specialized categories. The Council for Responsible Nutrition's February 2025 '2024 Consumer Survey on Dietary Supplements' reported that 75% of Americans continued using dietary supplements, with probiotics remaining a top specialty choice alongside sleep aids. This forward-thinking mindset is particularly strong in emerging markets where rising disposable incomes coincide with improved health literacy. Highlighting this regional vitality, the Asia Pacific region led in value sales in 2024, according to the International Probiotics Association, and is projected to maintain a 9.2% growth rate through 2028, surpassing other established territories.

Market Challenge

The stringent regulatory framework governing health claims and product stability poses a persistent impediment to the vigorous expansion of the global probiotics dietary supplements market. Unlike conventional dietary formulations, probiotics incorporate live microorganisms that must maintain viability from production through to consumption, demanding extensive and costly stability testing. Regulatory bodies enforce rigorous standards for health claims, compelling manufacturers to invest significant capital in scientific validation and clinical trials to ensure adherence to labeling requirements. This substantial financial burden forces companies to reallocate resources away from market expansion and consumer education, directly diminishing the speed at which new products can be introduced and stifling the overall momentum of the industry. Consequently, these regulatory complexities establish high barriers to entry that disproportionately impact smaller or emerging brands, which frequently lack the necessary financial resources to navigate such demands. This dynamic creates a market environment largely dominated by established players and restricts the influx of diverse, innovative solutions that could otherwise address evolving consumer health needs. Although the global probiotic supplements market was projected to grow at a rate of 7.5% over the next four years as per the International Probiotics Association in 2024, this positive growth trajectory is invariably tempered by these regulatory hurdles, which cap the potential for more rapid product diversification and broader market penetration.

Market Trends

A significant shift is occurring in the market with the emergence of psychobiotics, as consumers increasingly leverage the gut-brain axis to support mental well-being and enhance stress resilience. This trend extends beyond conventional digestive health applications, positioning probiotics as functional tools for mood regulation and improved sleep quality. Manufacturers are responding by commercializing specific strains that have been clinically demonstrated to modulate neurotransmitter production, thereby catering to a demographic that regards mental health as a fundamental aspect of physical vitality. According to the Council for Responsible Nutrition's February 2025 '2024 Consumer Survey on Dietary Supplements', 19% of consumers cited mental health and 22% cited sleep health as key reasons for taking supplements, indicating a considerable broadening of the category's appeal beyond solely gut-focused issues. Simultaneously, the incorporation of probiotics into sports nutrition is redefining the active lifestyle segment. Brands are developing "protein-plus" solutions where probiotics are added to enhance nutrient absorption, reduce exercise-induced inflammation, and support immune recovery in athletes. This integration allows probiotics to penetrate the mainstream active nutrition market, transitioning from standalone pills to functional powders and beverages. This evolution is underpinned by the surging demand for protein-enriched diets among general consumers, creating fertile ground for synbiotic fortifications. FrieslandCampina Ingredients' January 2025 'Nutritional Trends 2025' report noted that 71% of global consumers actively prioritize protein in their diets, a substantial increase from 59% in 2022, signaling a massive opportunity for probiotic strains that can be co-formulated into high-protein applications.

Key Market Players

• Vitakem Nutraceutical Inc
• Lesaffre International Corp
• DuPont de Nemours Inc
• H&H Group PLC
• Amway Corp
• Abbott Laboratories Inc
• Bayer AG
• Pfizer Inc.
• GSK PLC
• BASF SE

Report Scope

In this report, the Global Probiotics Dietary Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Probiotics Dietary Supplements Market, By Form

• Chewables & Gummies
• Capsules
• Powders
• Tablets & Softgels
• Others

Probiotics Dietary Supplements Market, By End-use

• Infants
• Children
• Adults
• Geriatric

Probiotics Dietary Supplements Market, By Applications

• Sports Fitness
• Energy & Weight Management
• General Health
• Bone & Joint Health
• Gastrointestinal Health
• Immunity
• Cardiac Health
• Diabetes
• Anti-cancer
• Skin/Hair/Nails
• Brain/Mental Health
• Others

Probiotics Dietary Supplements Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Probiotics Dietary Supplements Market.

Available Customizations:

Global Probiotics Dietary Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Probiotics Dietary Supplements Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Form (Chewables & Gummies, Capsules, Powders, Tablets & Softgels, Others)
  • 5.2.2. By End-use (Infants, Children, Adults, Geriatric)
  • 5.2.3. By Applications (Sports Fitness, Energy & Weight Management, General Health, Bone & Joint Health, Gastrointestinal Health, Immunity, Cardiac Health, Diabetes, Anti-cancer, Skin/Hair/Nails, Brain/Mental Health, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Probiotics Dietary Supplements Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Form
  • 6.2.2. By End-use
  • 6.2.3. By Applications
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Probiotics Dietary Supplements Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Form
      • 6.3.1.2.2. By End-use
      • 6.3.1.2.3. By Applications
  • 6.3.2. Canada Probiotics Dietary Supplements Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Form
      • 6.3.2.2.2. By End-use
      • 6.3.2.2.3. By Applications
  • 6.3.3. Mexico Probiotics Dietary Supplements Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Form
      • 6.3.3.2.2. By End-use
      • 6.3.3.2.3. By Applications

7. Europe Probiotics Dietary Supplements Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Form
  • 7.2.2. By End-use
  • 7.2.3. By Applications
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Probiotics Dietary Supplements Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Form
      • 7.3.1.2.2. By End-use
      • 7.3.1.2.3. By Applications
  • 7.3.2. France Probiotics Dietary Supplements Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Form
      • 7.3.2.2.2. By End-use
      • 7.3.2.2.3. By Applications
  • 7.3.3. United Kingdom Probiotics Dietary Supplements Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Form
      • 7.3.3.2.2. By End-use
      • 7.3.3.2.3. By Applications
  • 7.3.4. Italy Probiotics Dietary Supplements Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Form
      • 7.3.4.2.2. By End-use
      • 7.3.4.2.3. By Applications
  • 7.3.5. Spain Probiotics Dietary Supplements Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Form
      • 7.3.5.2.2. By End-use
      • 7.3.5.2.3. By Applications

8. Asia Pacific Probiotics Dietary Supplements Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Form
  • 8.2.2. By End-use
  • 8.2.3. By Applications
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Probiotics Dietary Supplements Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Form
      • 8.3.1.2.2. By End-use
      • 8.3.1.2.3. By Applications
  • 8.3.2. India Probiotics Dietary Supplements Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Form
      • 8.3.2.2.2. By End-use
      • 8.3.2.2.3. By Applications
  • 8.3.3. Japan Probiotics Dietary Supplements Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Form
      • 8.3.3.2.2. By End-use
      • 8.3.3.2.3. By Applications
  • 8.3.4. South Korea Probiotics Dietary Supplements Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Form
      • 8.3.4.2.2. By End-use
      • 8.3.4.2.3. By Applications
  • 8.3.5. Australia Probiotics Dietary Supplements Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Form
      • 8.3.5.2.2. By End-use
      • 8.3.5.2.3. By Applications

9. Middle East & Africa Probiotics Dietary Supplements Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Form
  • 9.2.2. By End-use
  • 9.2.3. By Applications
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Probiotics Dietary Supplements Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Form
      • 9.3.1.2.2. By End-use
      • 9.3.1.2.3. By Applications
  • 9.3.2. UAE Probiotics Dietary Supplements Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Form
      • 9.3.2.2.2. By End-use
      • 9.3.2.2.3. By Applications
  • 9.3.3. South Africa Probiotics Dietary Supplements Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Form
      • 9.3.3.2.2. By End-use
      • 9.3.3.2.3. By Applications

10. South America Probiotics Dietary Supplements Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Form
  • 10.2.2. By End-use
  • 10.2.3. By Applications
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Probiotics Dietary Supplements Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Form
      • 10.3.1.2.2. By End-use
      • 10.3.1.2.3. By Applications
  • 10.3.2. Colombia Probiotics Dietary Supplements Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Form
      • 10.3.2.2.2. By End-use
      • 10.3.2.2.3. By Applications
  • 10.3.3. Argentina Probiotics Dietary Supplements Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Form
      • 10.3.3.2.2. By End-use
      • 10.3.3.2.3. By Applications

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Probiotics Dietary Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Vitakem Nutraceutical Inc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Lesaffre International Corp
• 15.3. DuPont de Nemours Inc
• 15.4. H&H Group PLC
• 15.5. Amway Corp
• 15.6. Abbott Laboratories Inc
• 15.7. Bayer AG
• 15.8. Pfizer Inc.
• 15.9. GSK PLC
• 15.10. BASF SE

16. Strategic Recommendations

17. About Us & Disclaimer